Click for best price
Hospital Acquired Infections Control Market Size, Share 2022
Infection control in health care facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acquired during the course of health care is known as a nosocomial, or hospital acquired, infection. The infection may occur in a postoperative wound or as a complication unrelated to the disease or condition.
This report contains market size and forecasts of Hospital Acquired Infections Control in Global, including the following market information:
Global Hospital Acquired Infections Control Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hospital Acquired Infections Control market was valued at 5867.2 million in 2021 and is projected to reach US$ 7101.9 million by 2028, at a CAGR of 2.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Education Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hospital Acquired Infections Control include AstraZeneca, GlaxoSmithKline, Merck and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hospital Acquired Infections Control companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital Acquired Infections Control Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hospital Acquired Infections Control Market Segment Percentages, by Type, 2021 (%)
Education
Medical Device Disinfection
Screening
Environmental Control
Global Hospital Acquired Infections Control Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hospital Acquired Infections Control Market Segment Percentages, by Application, 2021 (%)
General Hospital
Infectious Disease Hospital
Global Hospital Acquired Infections Control Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hospital Acquired Infections Control Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hospital Acquired Infections Control revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hospital Acquired Infections Control revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
GlaxoSmithKline
Merck
Pfizer
| Report Attributes |
Report Details |
| Report Title |
Hospital Acquired Infections Control Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hospital Acquired Infections Control Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital Acquired Infections Control Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hospital Acquired Infections Control Overall Market Size
2.1 Global Hospital Acquired Infections Control Market Size: 2021 VS 2028
2.2 Global Hospital Acquired Infections Control Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hospital Acquired Infections Control Players in Global Market
3.2 Top Global Hospital Acquired Infections Control Companies Ranked by Revenue
3.3 Global Hospital Acquired Infections Control Revenue by Companies
3.4 Top 3 and Top 5 Hospital Acquired Infections Control Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hospital Acquired Infections Control Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital Acquired Infections Control Players in Global Market
3.6.1 List of Global Tier 1 Hospital Acquired Infections Control Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital Acquired Infections Control Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Hospital Acquired Infections Control Market Size Markets, 2021 & 2028
4.1.2 Education
4.1.3 Medical Device Disinfection
4.1.4 Screening
4.1.5 Environmental Control
4.2 By Type - Global Hospital Acquired Infections Control Revenue & Forecasts
4.2.1 By Type - Global Hospital Acquired Infections Control Revenue, 2017-2022
4.2.2 By Type - Global Hospital Acquired Infections Control Revenue, 2023-2028
4.2.3 By Type - Global Hospital Acquired Infections Control Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hospital Acquired Infections Control Market Size, 2021 & 2028
5.1.2 General Hospital
5.1.3 Infectious Disease Hospital
5.2 By Application - Global Hospital Acquired Infections Control Revenue & Forecasts
5.2.1 By Application - Global Hospital Acquired Infections Control Revenue, 2017-2022
5.2.2 By Application - Global Hospital Acquired Infections Control Revenue, 2023-2028
5.2.3 By Application - Global Hospital Acquired Infections Control Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Hospital Acquired Infections Control Market Size, 2021 & 2028
6.2 By Region - Global Hospital Acquired Infections Control Revenue & Forecasts
6.2.1 By Region - Global Hospital Acquired Infections Control Revenue, 2017-2022
6.2.2 By Region - Global Hospital Acquired Infections Control Revenue, 2023-2028
6.2.3 By Region - Global Hospital Acquired Infections Control Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Hospital Acquired Infections Control Revenue, 2017-2028
6.3.2 US Hospital Acquired Infections Control Market Size, 2017-2028
6.3.3 Canada Hospital Acquired Infections Control Market Size, 2017-2028
6.3.4 Mexico Hospital Acquired Infections Control Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Hospital Acquired Infections Control Revenue, 2017-2028
6.4.2 Germany Hospital Acquired Infections Control Market Size, 2017-2028
6.4.3 France Hospital Acquired Infections Control Market Size, 2017-2028
6.4.4 U.K. Hospital Acquired Infections Control Market Size, 2017-2028
6.4.5 Italy Hospital Acquired Infections Control Market Size, 2017-2028
6.4.6 Russia Hospital Acquired Infections Control Market Size, 2017-2028
6.4.7 Nordic Countries Hospital Acquired Infections Control Market Size, 2017-2028
6.4.8 Benelux Hospital Acquired Infections Control Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Hospital Acquired Infections Control Revenue, 2017-2028
6.5.2 China Hospital Acquired Infections Control Market Size, 2017-2028
6.5.3 Japan Hospital Acquired Infections Control Market Size, 2017-2028
6.5.4 South Korea Hospital Acquired Infections Control Market Size, 2017-2028
6.5.5 Southeast Asia Hospital Acquired Infections Control Market Size, 2017-2028
6.5.6 India Hospital Acquired Infections Control Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Hospital Acquired Infections Control Revenue, 2017-2028
6.6.2 Brazil Hospital Acquired Infections Control Market Size, 2017-2028
6.6.3 Argentina Hospital Acquired Infections Control Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital Acquired Infections Control Revenue, 2017-2028
6.7.2 Turkey Hospital Acquired Infections Control Market Size, 2017-2028
6.7.3 Israel Hospital Acquired Infections Control Market Size, 2017-2028
6.7.4 Saudi Arabia Hospital Acquired Infections Control Market Size, 2017-2028
6.7.5 UAE Hospital Acquired Infections Control Market Size, 2017-2028
7 Players Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Hospital Acquired Infections Control Major Product Offerings
7.1.4 AstraZeneca Hospital Acquired Infections Control Revenue in Global Market (2017-2022)
7.1.5 AstraZeneca Key News
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporate Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Hospital Acquired Infections Control Major Product Offerings
7.2.4 GlaxoSmithKline Hospital Acquired Infections Control Revenue in Global Market (2017-2022)
7.2.5 GlaxoSmithKline Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Hospital Acquired Infections Control Major Product Offerings
7.3.4 Merck Hospital Acquired Infections Control Revenue in Global Market (2017-2022)
7.3.5 Merck Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Hospital Acquired Infections Control Major Product Offerings
7.4.4 Pfizer Hospital Acquired Infections Control Revenue in Global Market (2017-2022)
7.4.5 Pfizer Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hospital Acquired Infections Control Market Opportunities & Trends in Global Market
Table 2. Hospital Acquired Infections Control Market Drivers in Global Market
Table 3. Hospital Acquired Infections Control Market Restraints in Global Market
Table 4. Key Players of Hospital Acquired Infections Control in Global Market
Table 5. Top Hospital Acquired Infections Control Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hospital Acquired Infections Control Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hospital Acquired Infections Control Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hospital Acquired Infections Control Product Type
Table 9. List of Global Tier 1 Hospital Acquired Infections Control Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital Acquired Infections Control Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Hospital Acquired Infections Control Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hospital Acquired Infections Control Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hospital Acquired Infections Control Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Hospital Acquired Infections Control Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hospital Acquired Infections Control Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hospital Acquired Infections Control Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Hospital Acquired Infections Control Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hospital Acquired Infections Control Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hospital Acquired Infections Control Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hospital Acquired Infections Control Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hospital Acquired Infections Control Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hospital Acquired Infections Control Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hospital Acquired Infections Control Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hospital Acquired Infections Control Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Hospital Acquired Infections Control Product Offerings
Table 32. AstraZeneca Hospital Acquired Infections Control Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline Corporate Summary
Table 34. GlaxoSmithKline Hospital Acquired Infections Control Product Offerings
Table 35. GlaxoSmithKline Hospital Acquired Infections Control Revenue (US$, Mn), (2017-2022)
Table 36. Merck Corporate Summary
Table 37. Merck Hospital Acquired Infections Control Product Offerings
Table 38. Merck Hospital Acquired Infections Control Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Hospital Acquired Infections Control Product Offerings
Table 41. Pfizer Hospital Acquired Infections Control Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Hospital Acquired Infections Control Segment by Type in 2021
Figure 2. Hospital Acquired Infections Control Segment by Application in 2021
Figure 3. Global Hospital Acquired Infections Control Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hospital Acquired Infections Control Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hospital Acquired Infections Control Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital Acquired Infections Control Revenue in 2021
Figure 8. By Type - Global Hospital Acquired Infections Control Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hospital Acquired Infections Control Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hospital Acquired Infections Control Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hospital Acquired Infections Control Revenue Market Share, 2017-2028
Figure 12. US Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hospital Acquired Infections Control Revenue Market Share, 2017-2028
Figure 16. Germany Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 17. France Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hospital Acquired Infections Control Revenue Market Share, 2017-2028
Figure 24. China Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 28. India Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hospital Acquired Infections Control Revenue Market Share, 2017-2028
Figure 30. Brazil Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hospital Acquired Infections Control Revenue Market Share, 2017-2028
Figure 33. Turkey Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hospital Acquired Infections Control Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Hospital Acquired Infections Control Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline Hospital Acquired Infections Control Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck Hospital Acquired Infections Control Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Hospital Acquired Infections Control Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
